iBio
IBIO
#10296
Rank
C$73.59 M
Marketcap
C$1.04
Share price
-4.00%
Change (1 day)
-32.29%
Change (1 year)

Earnings for iBio (IBIO)

Earnings in 2026 (TTM): -C$46.02 Million

According to iBio's latest financial reports the company's current earnings are C$0.1 Million. In 2025 the company made an earning of -C$35.07 Million a decrease over its 2024 earnings that were of -C$20 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for iBio from 2008 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) -C$46.02 Million31.22%
2025 -C$35.07 Million75.34%
2024 -C$20 Million-32.2%
2023 -C$29.5 Million-50.39%
2022 -C$59.46 Million122.23%
2021 -C$26.76 Million-12.52%
2020 -C$30.59 Million45%
2019 -C$21.1 Million-3.71%
2018 -C$21.91 Million5.52%
2017 -C$20.76 Million18.82%
2016 -C$17.47 Million60.34%
2015 -C$10.9 Million38.31%
2014 -C$7.88 Million25.01%
2013 -C$6.31 Million
2010 -C$17.47 Million360.89%
2009 -C$3.8 Million5.77%
2008 -C$3.59 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Johnson & Johnson
JNJ
C$26.72 B-56,845.78%๐Ÿ‡บ๐Ÿ‡ธ USA
Genocea Biosciences
GNCA
-C$53.1 Million 12.73%๐Ÿ‡บ๐Ÿ‡ธ USA
Nektar Therapeutics
NKTR
-C$0.22 Billion 364.11%๐Ÿ‡บ๐Ÿ‡ธ USA
Emergent BioSolutions
EBS
-C$0.28 Billion 489.86%๐Ÿ‡บ๐Ÿ‡ธ USA